Biosimilars in oncology: Effects on economy and therapeutic innovations.

Hübel, Kai; Kron, Florian; Lux, Michael Patrick

Hübel, Kai; Kron, Florian; Lux, Michael Patrick.

Afiliação

Hübel K; University of Cologne, Faculty of Medicine and University Hospital of Cologne, Dept. I of Internal Medicine, Kerpener Str. 62, 50937, Köln, Germany. Electronic address: kai.huebel@uni-koeln.de.
Kron F; University of Cologne, Faculty of Medicine and University Hospital of Cologne, Dept. I of Internal Medicine, Kerpener Str. 62, 50937, Köln, Germany; FOM University of Applied Sciences, Herkulesstraße 32; 45127, Essen, Germany. Electronic address: florian.kron@uk-koeln.de.
Lux MP; Kooperatives Brustzentrum Paderborn, Klinik für Gynäkologie und Geburtshilfe, Frauenklinik St. Louise, Paderborn, Frauenklinik St. Josefs, Salzkotten, Frauen- und Kinderklinik St. Louise, Husener Str. 81, 33098, Paderborn, Germany. Electronic address: M.Lux@vincenz.de.

Eur J Cancer ; 139: 10-19, 2020 11.

Article em En | MEDLINE | ID: mdl-32950935

Assuntos

Medicamentos Biossimilares/uso terapêutico; Neoplasias da Mama/tratamento farmacológico; Feminino; Filgrastim/uso terapêutico; Fator Estimulador de Colônias de Granulócitos/uso terapêutico; Humanos; Linfoma Folicular/tratamento farmacológico; Oncologia/métodos; Polietilenoglicóis/uso terapêutico; Rituximab/uso terapêutico; Trastuzumab/uso terapêutico

Palavras-chave

Biosimilar pharmaceuticals; Breast cancer; Filgrastim; Granulocyte colony-stimulating factor; Health economics; Oncological therapies; Rituximab; Trastuzumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Temas: ECOS / Aspectos_gerais Bases de dados: MEDLINE Assunto principal: Medicamentos Biossimilares Tipo de estudo: Health_economic_evaluation Limite: Female / Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google